Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia—A Brief Review of Current Data
by Alok Singh, MD Dr. Singh is with All India Institute of Medical Sciences in Raipur, India. Funding: No funding was provided for this study. Disclosures: The author has no conflicts of interest relevant to [...]
Virtual and Augmented Reality-based Treatments for Phantom Limb Pain: A Systematic Review
by Andrew Yimu Vassantachart, MD; Elizabeth Yeo, MD; and Brian Chau, MD Dr. Vassantachart is with Loma Linda University School of Medicine in Loma Linda, California. Dr. Yeo is with the Department of Physical Medicine [...]
Risk Management: Top 25 Tips to Reduce Clinicians’ Stress Levels
by Donna Vanderpool, MBA, JD Ms. Vanderpool is the Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an [...]
Letter to the Editor: Steroid Management in a Patient with Myasthenia Gravis Undergoing COVID-19 Vaccination
Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(7–9):8. Dear Editor: We report [...]
Bipolar I Disorder Exacerbation Following COVID-19 Vaccination
by Jeffrey Guina, MD; Sara Barlow, BS; and Duren Gutierrez, DNP Dr. Guina and Ms. Barlow are with Oakland University William Beaumont School of Medicine in Rochester, Michigan. Drs. Guina and Gutierrez are with Easterseals [...]
Post-stroke Sexual Dysfunction in Men: Epidemiology, Diagnostic Work-up, and Treatment
by Rocco Salvatore Calabrò, MD, PhD Dr. Calabrò is with IRCCS Centro Neurolesi “Bonino-Pulejo” in Messina, Italy. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest relevant to [...]
Personality Disorders in Patients with Intellectual Disability
by Julie P. Gentile MD, MBA; Nita V. Bhatt MD, MPH; Jesse P. Cannella, BS; Kari Harper, MD; and John Johnson, MD, MBA Dr. Gentile is Professor and Chair of the Department of Psychiatry at [...]
Pre-, Peri-, and Neonatal Factors Associated with Autism Spectrum Disorder: Results of a Lebanese Case-control Study
by Aline Hajj, PharmD, PhD; Souheil Hallit, PharmD, MSc, MPH, PhD; Rouba El-Khatib, PharmD; Sandra Abi Haidar, PharmD; Fabienne Hajj Moussa Lteif, MSc; Layal Hajj, MSc; Maguy Moudawar, MSc; and Lydia Rabbaa Khabbaz, PharmD, PhD [...]
Past Articles
GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide)
by Senthil Vel Rajan Rajaram Manoharan, MD, and Rohit Madan, MD Dr. Manoharan is with Huntsville Hospital/University of Alabama at Birmingham – Huntsville Campus in Huntsville, Alabama. Dr. Madan is with University of Arizona College [...]
The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA, BCGP, BCPP; EILEEN TRIGOBOFF, RN, PMHCNS-BC, DNS, DABFN; and CLAUDIA LEE, MD Dr. O’Donnell is with Edward Hines Jr. Veterans Administration Hospital in Hines, Illinois, [...]
Risk Management: EHR Use and Emerging Risks
by Justin A. Pope, JD Mr. Pope is a Senior Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is an employee [...]
Letter to the Editor: The Catastrophic Perception of Pain in Burning Mouth Syndrome May be Associated with Sympathetic Tone as Indicated by the QTc Interval
Innov Clin Neurosci. 2024;21(1–3):8–9. Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: Unexplained somatic symptoms [...]
Artificial Intelligence and Neurorehabilitation: Fact vs. Fiction
by Nicola Fiorente, MD; Sepehr Mojdehdehbaher, BSc; and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio and Sport in Cittadella (PD), Italy. Dr. Mojdehdehbaher is with Engineering Department, University of Messina in [...]
Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown University Medical School in Washington, [...]
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward
by William P. Horan, PhD; Gary Sachs, MD; Dawn I. Velligan, PhD; Michael Davis, MD, PhD; Richard S.E. Keefe, PhD; Ni A. Khin, MD; Florence Butlen-Ducuing, MD, PhD; and Philip D. Harvey, PhD Dr. Horan [...]
Health Anxiety, Fear of COVID-19, Nosophobia, and Health-protective Behaviors Among Healthcare Professionals
by Uzma Ilyas, PhD scholar; Farwa Aslam, MS; Muqadas Fatima, MS; Zarmin Tariq, MS; and Prof Dr. Usman Hotiana, MBBS, FCPS (Psychology) Ms. Ilyas is Principal Lecturer, Psychology Department, University of Central Punjab in Lahore, [...]